MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Cardiosolutions raises $3.3M | Funding Roundup

Cardiosolutions raises $3.3M | Funding Roundup

By

Cardiosolutions

Cardiosolutions Inc. landed about half of what it hopes will amount to a $6.5 million fundraising round, pulling in $3.3 million from eight un-named investors, according to a regulatory filing.

The Stoughton, Mass.-based company is a spinout from contract manufacturer STD Med, which early last year bought a new, 32,000-square-foot cleanroom to house Cardiosolutions and sister firm Spirus Medical Inc.

Cardiosolutions, which is developing a catheter-based mitral valve replacement technology, netted $295,000 in a debt sale in January 2010. The latest offering is also a debt sale, according to a filing with the federal Securities & Exchange Commission.

Sign up to get our free newsletters delivered right to your inbox

In September 2010, Cardiosolutions won 510(k) clearance from the Food & Drug Administration for its Percu-Pro guidewire.

Read more med-tech funding news from MassDevice.com

OnPoint Medical Diagnostics lands half of $1.5M round

OnPoint Medical Diagnostics Inc. raised $750,000 of a $1.5 million debt, options and warrants round.

The Rochester, Minn.-based company makes software to manage MRI scanners in hospitals and other clinical settings. The software automates a mandatory accreditation process for federal reimbursement.

The funding round was backed by 12 un-named investors, according to a regulatory filing. Read more

Ohio Third Frontier shells out $2.6 million in CT, PET grants

The Ohio Third Frontier Commission is doling out nearly $2.6 million in grants to Case Western Reserve University, Philips Healthcare and University Hospitals for CT and PET scanning research.

The commission’s medical imaging program aims to nurture the Buckeye State’s medical imaging industry. It’s based in Columbus, Ohio. Read more

MedShape Solutions reels in $1.5M SBIR grant

MedShape Solutions Inc. reeled in a Small Business Innovation Research Phase I grant from the National Institutes of Health that could eventually reach $1.5 million if the company meets its milestones.

The Atlanta-based medical device maker said the grant will fund research and development of a “compliant shape memory polymer device for meniscal repair,” according to a press release.

“MedShape’s research and development team will use the company’s proprietary shape memory biopolymer capabilities to develop an easy-to-use, robust, and effective meniscal repair solution with clearly defined clinical benefits,” according to the release. Read more

NeuroSigma wins $750k STTR grant

The NIH also handed out some cash to NeuroSigma Inc., a Los Angeles-based medical device company that’s working on a neurostimulation device to treat drug-resistant epilepsy.

The Small Business Technology Transfer Phase I grant from the National Institute of Neurological Disorders and Stroke “will support further development of external trigeminal nerve stimulation therapy for the treatment of drug-resistant epilepsy, for which NeuroSigma is the exclusive worldwide licensee of intellectual property developed by the University of California, Los Angeles,” according to a press release.

The two-year, $750,000 award could include up to $3 million in follow-on Phase II grants for further clinical research if the Phase I study pans out, according to the release. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • EPA delayed notifying residents of ethylene oxide emissions
    The EPA delayed notifying neighbors of an Illinois medical device sterilization plant of ethylene oxide (EtO) emissions the agency measured in 2018, according to an inspector general’s report released yesterday. The report also says that “leadership” in the agency’s Office of Air and Radiation also failed to conduct public meetings with residents either near the… […]
  • 9 medical devices you should keep an eye out for in 2021
    The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek… […]
  • Greenlight Guru to provide QMS to NIH diagnostics program
    NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]
  • MicroCare names CFO
    MicroCare (New Britain, Conn.) has announced the appointment of John Stardellis as the company’s new chief financial officer (CFO). Stardellis joins MicroCare with more than 20 years’ experience in a variety of finance, policy and operational leadership roles. Most recently, he served as CFO at i-Health, a division of DSM Nutritional Products. “John’s track record with… […]
  • Mayo Clinic helps launch two new companies for improved diagnostics
    Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. Get the full story… […]
  • Intertek gains FDA nod for premarket device testing
    Intertek has won accreditation under an FDA pilot program for testing laboratories, the company said this week. The accreditation authorizes Intertek’s 12 “medical centers of excellence” to perform premarket testing of devices for the U.S. market. The Accreditation Scheme for Conformity Assessment pilot program is a voluntary program developed to provide increased confidence in testing… […]
  • HHS shoots down ‘flawed’ plan to let some devices skip review
    The Biden administration has nixed what it described as a “flawed” Trump-era decision to exempt certain medical devices — including infusion pump controllers and fetal monitors — from regulatory review. HHS published the original notice in the Federal Register on Jan. 15, shortly before President Joe Biden was set to take office, without speaking with… […]
  • More than 50 medtech testing sites win FDA pilot accreditation
    The FDA announced today that more than 50 laboratory sites were chosen to participate in its program for streamlined regulatory reviews. In total, 53 sites made the FDA’s initial list for participation in its Accreditation Scheme for Conformity Assessment (ASCA) program, which will set out to support more streamlined regulatory reviews of medical device market… […]
  • Medline Industries up for sale?
    Medline Industries is looking for a buyer in a deal that could be worth $30 billion, according to a report in the Wall Street Journal. The Journal cites “people familiar with the matter” saying that Northfield, Ill.-based Medline has hired Goldman Sachs to manage the process. The people added that the company might alternatively seek… […]
  • Micro to add plant in Costa Rica
    Contract manufacturer Micro today announced plans to open a new plant in Costa Rica. The 32,000 ft² facility will significantly increase Micro’s cleanroom assembly capacity, according to the Somerset, N.J.-based company. It will be located in the Zona Franca Metro business park and is expected to open in late 2021 with operations beginning in 2022.… […]
  • Survey shows solid medical device industry performance despite pandemic
    By Stewart Eisenhart, Emergo Group Medical device and IVD manufacturers report healthy performance over the course of 2020, but also faced significant operational and regulatory challenges related to the coronavirus pandemic. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not… […]

Leave a Reply